Ali Shatha Hussain, Mohammed Rasha Kasim, Saheb Hussein Ali, Abdulmajeed Ban A
College of Medicine, Al-Nahrain University, Baghdad, Iraq.
Al-Imamein Al-Kadhimein Medical City, Baghdad, Iraq.
Int J Nephrol. 2017;2017:1407506. doi: 10.1155/2017/1407506. Epub 2017 Apr 26.
. The polymorphism R229Q is one of the most commonly reported podocin sequence variations among steroid-resistant nephrotic syndromes (SRNS). . We investigated the frequency and risk of this polymorphism among a group of Iraqi children with SRNS and steroid-sensitive nephrotic syndrome (SSNS). . A prospective case control study which was conducted in Al-Imamein Al-Kadhimein Medical City, spanning the period from the 1st of April 2015 to 30th of November 2015. Study sample consisted of 54 children having NS, divided into 2 groups: patients group consisted of 27 children with SRNS, and control group involved 27 children with SSNS. Both were screened by real time polymerase chain reaction for R229Q in exon 5 of NPHS2 gene. . Molecular study showed R229Q polymorphism in 96.3% of SRNS and 100% of SSNS. There were no phenotypic or histologic characteristics of patients bearing homozygous R229Q polymorphism and the patients with heterozygous R229Q polymorphism. . Polymorphism R229Q of NPHS2 gene is prevalent in Iraqi children with SRNS and SSNS. Further study needs to be done, for other exons and polymorphism of NPHS2 gene in those patients.
R229Q多态性是类固醇抵抗型肾病综合征(SRNS)中最常报道的足突蛋白序列变异之一。我们调查了一组伊拉克SRNS患儿和类固醇敏感型肾病综合征(SSNS)患儿中这种多态性的频率和风险。在卡迪米因伊玛目医疗城进行了一项前瞻性病例对照研究,时间跨度为2015年4月1日至2015年11月30日。研究样本包括54名肾病患儿,分为两组:患者组由27名SRNS患儿组成,对照组包括27名SSNS患儿。两组均通过实时聚合酶链反应对NPHS2基因第5外显子的R229Q进行筛查。分子研究显示,96.3%的SRNS患儿和100%的SSNS患儿存在R229Q多态性。携带纯合R229Q多态性的患者和携带杂合R229Q多态性的患者没有表型或组织学特征。NPHS2基因的R229Q多态性在伊拉克SRNS和SSNS患儿中普遍存在。对于这些患者的NPHS2基因其他外显子和多态性,还需要进一步研究。